Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy-Reference-Cited by-同舟云学术

Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy

Published:2015-08 Issue:8 Volume:34 Page:1050-1057
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Coutance Guillaume,Ouldamar Salima,Rouvier Philippe,Saheb Samir,Suberbielle Caroline,Bréchot Nicolas,Hariri Sarah,Lebreton Guillaume,Leprince Pascal,Varnous Shaida

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference20 articles.

1. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

2. Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation;Sureshkumar;Clin Nephrol,2012

3. Report from a consensus conference on antibody-mediated rejection in heart transplantation;Kobashigawa;J Heart Lung Transplant,2011

4. Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody;Hodges;Transplantation,2012

5. De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival;Smith;Am J Transplant,2011

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening of cardiac allograft vasculopathy in heart transplant patients with coronary computed tomography angiography;Monaldi Archives for Chest Disease;2024-02-12

2. Heart transplantation and biomarkers: a review about their usefulness in clinical practice;Frontiers in Cardiovascular Medicine;2024-01-24

3. De Novo Donor-Specific Antibodies after Heart Transplantation: A Comprehensive Guide for Clinicians;Journal of Clinical Medicine;2023-12-02

4. Antibody Mediated Rejection is not Associated with Worse Survival in Adherent Heart Transplant Patients in the Contemporary Era;2023-12-02

5. Blockade of BLyS inhibits B-cell responses and antibody production for the prevention of chronic transplant rejection;The Journal of Heart and Lung Transplantation;2023-12